首页> 外文期刊>Clinical cardiology. >Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy
【24h】

Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy

机译:了解患者对他汀类药物和药物治疗的依从性和担忧与医生的讨论(行动):一项针对患者与他汀类药物治疗与医疗保健提供者对话的观点的调查

获取原文
       

摘要

Background Statins are first‐line for cholesterol lowering and prevention of atherosclerotic cardiovascular disease (ASCVD), but their use is complicated by side effects and potential for drug–drug interactions. Provider‐patient communication is the basis of the recommended shared decision‐making, but relatively little is known about this in the context of statin use. Methods We surveyed 5014 US adults prescribed a statin for hypercholesterolemia to learn their perspectives on communication with their provider. Results Ninety‐four percent reported currently taking a statin while 6% had stopped. Past users vs current users were more likely to be female, age Conclusion Provider‐patient communication regarding statin therapy appears inadequate, by patient recall, and efforts to improve it are warranted.
机译:背景他汀类药物是降低胆固醇和预防动脉粥样硬化性心血管疾病(ASCVD)的一线药物,但由于副作用和药物与药物相互作用的潜力,其使用变得复杂。提供者与患者之间的交流是推荐的共同决策的基础,但在他汀类药物的使用中,对此知之甚少。方法我们调查了5014位美国处方高胆固醇血症他汀类药物的成年人,以了解他们与提供者沟通的观点。结果有94%的人报告目前正在服用他汀类药物,而6%的人已经停止使用他汀类药物。既往使用者与目前使用者之间的比较可能是女性,年龄结论通过患者的回忆,提供者与他汀类药物治疗的患者交流似乎不充分,因此有必要进行改进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号